var eventsData = [{"Ticker":"AVGO","EffectiveDate":"2016-12-14","Type":"Dividend","Title":"The Firm pays dividend $1.02","DailyReturn":"-0.44%","FiveDayReturnAfter":"2.02%","FiveDayReturnBefore":"8.53%"},{"Ticker":"AVGO","EffectiveDate":"2016-12-08","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2016 Q4's earning $3.47 per share and revenue $4146MM. This beats analyst's estimated EPS $3.38, beats estimated revenue $4120MM.","DailyReturn":"1.28%","FiveDayReturnAfter":"5.81%","FiveDayReturnBefore":"-1.14%"},{"Ticker":"AVGO","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on AVGO to Buy. Target Price is $206.","DailyReturn":"-0.82%","FiveDayReturnAfter":"6.99%","FiveDayReturnBefore":"-5%"},{"Ticker":"AVGO","EffectiveDate":"2016-11-03","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Overweight.","DailyReturn":"0.24%","FiveDayReturnAfter":"0.49%","FiveDayReturnBefore":"-0.25%"},{"Ticker":"AVGO","EffectiveDate":"2016-10-06","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on AVGO to Market Perform.","DailyReturn":"0.4%","FiveDayReturnAfter":"-1.75%","FiveDayReturnBefore":"1.61%"},{"Ticker":"AVGO","EffectiveDate":"2016-10-05","Type":"RatingNeutral","Title":"Bernstein initiates coverage on AVGO to Outperform. Target Price is $215.","DailyReturn":"2.62%","FiveDayReturnAfter":"1.24%","FiveDayReturnBefore":"-1.06%"},{"Ticker":"AVGO","EffectiveDate":"2016-10-04","Type":"RatingNeutral","Title":"Bernstein initiates coverage on AVGO to Outperform. Target Price is $215.","DailyReturn":"-0.59%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-20","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on AVGO to Positive.","DailyReturn":"-1.46%","FiveDayReturnAfter":"-2.39%","FiveDayReturnBefore":"4.03%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $180; previously $200.","DailyReturn":"2.14%","FiveDayReturnAfter":"0.43%","FiveDayReturnBefore":"0.41%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-15","Type":"Dividend","Title":"The Firm pays dividend $0.51","DailyReturn":"2.14%","FiveDayReturnAfter":"0.43%","FiveDayReturnBefore":"0.41%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-06","Type":"RatingNeutral","Title":"Argus Research maintains AVGO to Buy. Target Price is $195; previously $184.","DailyReturn":"-1.16%","FiveDayReturnAfter":"-5.11%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-02","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $205; previously $185.","DailyReturn":"-2.24%","FiveDayReturnAfter":"-9.66%","FiveDayReturnBefore":"0.59%"},{"Ticker":"AVGO","EffectiveDate":"2016-09-01","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2016 Q3's earning $2.89 per share and revenue $3802MM. This beats analyst's estimated EPS $2.77, beats estimated revenue $3760MM.","DailyReturn":"0.37%","FiveDayReturnAfter":"-4.66%","FiveDayReturnBefore":"0.63%"},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Citigroup assumes AVGO to Buy. Target Price is $205.","DailyReturn":"-0.22%","FiveDayReturnAfter":"-3.61%","FiveDayReturnBefore":"0.83%"},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $200; previously $180.","DailyReturn":"-0.22%","FiveDayReturnAfter":"-3.61%","FiveDayReturnBefore":"0.83%"},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $185.","DailyReturn":"-0.22%","FiveDayReturnAfter":"-3.61%","FiveDayReturnBefore":"0.83%"},{"Ticker":"AVGO","EffectiveDate":"2016-08-12","Type":"RatingNeutral","Title":"Baird initiates coverage on AVGO to Outperform.","DailyReturn":"0.22%","FiveDayReturnAfter":"1.06%","FiveDayReturnBefore":"3%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-15","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.7%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $191; previously $182.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"RBC Capital maintains AVGO to Top Pick. Target Price is $185; previously $180.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"B. Riley maintains AVGO to Buy. Target Price is $200; previously $190.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains AVGO to Buy. Target Price is $211; previously $189.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $180; previously $170.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $185; previously $170.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $200; previously $180.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Buy. Target Price is $190; previously $180.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $190; previously $180.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $185; previously $171.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Cowen & Co. maintains AVGO to Outperform. Target Price is $200; previously $190.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains AVGO to Buy. Target Price is $200; previously $185.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Craig-Hallum maintains AVGO to Buy. Target Price is $200; previously $190.","DailyReturn":"4.93%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"0.86%"},{"Ticker":"AVGO","EffectiveDate":"2016-06-02","Type":"EarningsRelease","Title":"After market close, AVGO reports 2016 Q2's earning $2.53 per share and revenue $3562MM..","DailyReturn":"0.09%","FiveDayReturnAfter":"5.6%","FiveDayReturnBefore":"2.18%"},{"Ticker":"AVGO","EffectiveDate":"2016-05-17","Type":"RatingNeutral","Title":"CLSA initiates coverage on AVGO to Outperform. Target Price is $165.","DailyReturn":"-1.03%","FiveDayReturnAfter":"3.74%","FiveDayReturnBefore":"0.17%"},{"Ticker":"AVGO","EffectiveDate":"2016-05-02","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $171; previously $175.","DailyReturn":"0.22%","FiveDayReturnAfter":"-2.68%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"AVGO","EffectiveDate":"2016-04-18","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on AVGO to Outperform.","DailyReturn":"0.26%","FiveDayReturnAfter":"-3.37%","FiveDayReturnBefore":"-0.42%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-16","Type":"Dividend","Title":"The Firm pays dividend $0.49","DailyReturn":"0.43%","FiveDayReturnAfter":"4.48%","FiveDayReturnBefore":"6.13%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Overweight. Target Price is $175; previously $170.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"FBR Capital maintains AVGO to Outperform. Target Price is $185; previously $180.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $180; previously $157.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $162; previously $160.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $175; previously $155.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $200; previously $175.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $180; previously $160.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $182; previously $180.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.03%","FiveDayReturnBefore":"3.6%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-26","Type":"RatingNeutral","Title":"B. Riley initiates coverage on AVGO to Buy. Target Price is $175.","DailyReturn":"0.48%","FiveDayReturnAfter":"3.6%","FiveDayReturnBefore":"4.16%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-24","Type":"RatingNeutral","Title":"Sidoti & Co. maintains AVGO to Buy. Target Price is $168; previously $180.","DailyReturn":"1.7%","FiveDayReturnAfter":"7.7%","FiveDayReturnBefore":"1.5%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Credit Suisse assumes AVGO to Outperform. Target Price is $160.","DailyReturn":"3.76%","FiveDayReturnAfter":"7.12%","FiveDayReturnBefore":"-5.36%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Topeka initiates coverage on AVGO to Hold.","DailyReturn":"3.76%","FiveDayReturnAfter":"7.12%","FiveDayReturnBefore":"-5.36%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingUpgrade","Title":"JP Morgan upgrades AVGO to Overweight from Neutral. Target Price is $170.","DailyReturn":"3.76%","FiveDayReturnAfter":"7.12%","FiveDayReturnBefore":"-5.36%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-03","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on AVGO to Buy.","DailyReturn":"-1.41%","FiveDayReturnAfter":"-10.7%","FiveDayReturnBefore":"6.87%"},{"Ticker":"AVGO","EffectiveDate":"2016-02-02","Type":"RatingNeutral","Title":"Barclays initiates coverage on AVGO to Overweight. Target Price is $170.","DailyReturn":"-3.22%","FiveDayReturnAfter":"-12.2%","FiveDayReturnBefore":"10.07%"},{"Ticker":"AVGO","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on AVGO to Buy.","DailyReturn":"1.52%","FiveDayReturnAfter":"0.98%","FiveDayReturnBefore":"-7.78%"},{"Ticker":"AVGO","EffectiveDate":"2015-12-21","Type":"RatingUpgrade","Title":"RBC Capital upgrades AVGO to Top Pick from Outperform.","DailyReturn":"3.99%","FiveDayReturnAfter":"4.29%","FiveDayReturnBefore":"-2.65%"},{"Ticker":"AVGO","EffectiveDate":"2015-12-16","Type":"Dividend","Title":"The Firm pays dividend $0.44","DailyReturn":"0.73%","FiveDayReturnAfter":"1.57%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"AVGO","EffectiveDate":"2015-12-03","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $180; previously $170.","DailyReturn":"9.5%","FiveDayReturnAfter":"9.68%","FiveDayReturnBefore":"2.97%"},{"Ticker":"AVGO","EffectiveDate":"2015-12-01","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on AVGO to Positive. Target Price is $160.","DailyReturn":"1.87%","FiveDayReturnAfter":"13.18%","FiveDayReturnBefore":"3.15%"},{"Ticker":"AVGO","EffectiveDate":"2015-11-10","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on AVGO to Buy. Target Price is $156.","DailyReturn":"-5.24%","FiveDayReturnAfter":"-4.05%","FiveDayReturnBefore":"2.15%"},{"Ticker":"AVGO","EffectiveDate":"2015-09-16","Type":"Dividend","Title":"The Firm pays dividend $0.42","DailyReturn":"-1.84%","FiveDayReturnAfter":"-7.16%","FiveDayReturnBefore":"3.96%"},{"Ticker":"AVGO","EffectiveDate":"2015-09-10","Type":"RatingUpgrade","Title":"JMP Securities upgrades AVGO to Market Outperform from Market Perform. Target Price is $165.","DailyReturn":"1.21%","FiveDayReturnAfter":"3.65%","FiveDayReturnBefore":"6.32%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $159; previously $160.","DailyReturn":"8.65%","FiveDayReturnAfter":"6.52%","FiveDayReturnBefore":"-4.41%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $170; previously $180.","DailyReturn":"8.65%","FiveDayReturnAfter":"6.52%","FiveDayReturnBefore":"-4.41%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Buy. Target Price is $180; previously $179.","DailyReturn":"8.65%","FiveDayReturnAfter":"6.52%","FiveDayReturnBefore":"-4.41%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-26","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2015 Q3's earning $2.24 per share and revenue $1750MM. This beats analyst's estimated EPS $2.14, beats estimated revenue $1740MM.","DailyReturn":"7.08%","FiveDayReturnAfter":"9.53%","FiveDayReturnBefore":"-11.91%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-25","Type":"RatingUpgrade","Title":"CLSA upgrades AVGO to Buy from Outperform. Target Price is $150.","DailyReturn":"-1.3%","FiveDayReturnAfter":"13.61%","FiveDayReturnBefore":"-13.25%"},{"Ticker":"AVGO","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $165; previously $170.","DailyReturn":"0.52%","FiveDayReturnAfter":"-2.09%","FiveDayReturnBefore":"-2.63%"},{"Ticker":"AVGO","EffectiveDate":"2015-07-16","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on AVGO to Outperform. Target Price is $185.","DailyReturn":"2.26%","FiveDayReturnAfter":"-1.63%","FiveDayReturnBefore":"2.82%"},{"Ticker":"AVGO","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Argus Research initiates coverage on AVGO to Buy. Target Price is $163.","DailyReturn":"-1.17%","FiveDayReturnAfter":"-6.34%","FiveDayReturnBefore":"0.03%"},{"Ticker":"AVGO","EffectiveDate":"2015-06-17","Type":"Dividend","Title":"The Firm pays dividend $0.4","DailyReturn":"-0.63%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"1.26%"},{"Ticker":"AVGO","EffectiveDate":"2015-06-02","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on AVGO to Buy. Target Price is $180.","DailyReturn":"-1.67%","FiveDayReturnAfter":"-5.6%","FiveDayReturnBefore":"10.02%"},{"Ticker":"AVGO","EffectiveDate":"2015-05-29","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Overweight. Target Price is $180; previously $135.","DailyReturn":"3.99%","FiveDayReturnAfter":"-0.83%","FiveDayReturnBefore":"9.78%"},{"Ticker":"AVGO","EffectiveDate":"2015-05-29","Type":"RatingUpgrade","Title":"Jefferies upgrades AVGO to Buy from Hold. Target Price is $179; previously $125.","DailyReturn":"3.99%","FiveDayReturnAfter":"-0.83%","FiveDayReturnBefore":"9.78%"},{"Ticker":"AVGO","EffectiveDate":"2015-05-22","Type":"RatingNeutral","Title":"Mizuho initiates coverage on AVGO to Buy. Target Price is $150.","DailyReturn":"2.35%","FiveDayReturnAfter":"13.33%","FiveDayReturnBefore":"2.06%"},{"Ticker":"AVGO","EffectiveDate":"2015-05-12","Type":"RatingNeutral","Title":"Barclays assumes AVGO to Overweight. Target Price is $145.","DailyReturn":"0.11%","FiveDayReturnAfter":"5.82%","FiveDayReturnBefore":"1.35%"},{"Ticker":"AVGO","EffectiveDate":"2015-03-24","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $160; previously $131.","DailyReturn":"-0.98%","FiveDayReturnAfter":"-2.93%","FiveDayReturnBefore":"3.75%"},{"Ticker":"AVGO","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $160; previously $131.","DailyReturn":"0.86%","FiveDayReturnAfter":"-3.88%","FiveDayReturnBefore":"6.71%"},{"Ticker":"AVGO","EffectiveDate":"2015-03-18","Type":"Dividend","Title":"The Firm pays dividend $0.38","DailyReturn":"1.33%","FiveDayReturnAfter":"3.36%","FiveDayReturnBefore":"3.13%"},{"Ticker":"AVGO","EffectiveDate":"2015-03-16","Type":"RatingUpgrade","Title":"DA Davidson upgrades AVGO to Buy from Neutral. Target Price is $150; previously $125.","DailyReturn":"3.89%","FiveDayReturnAfter":"6.71%","FiveDayReturnBefore":"-2.28%"},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $135; previously $115.","DailyReturn":"14.7%","FiveDayReturnAfter":"13.83%","FiveDayReturnBefore":"2.4%"},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $131; previously $110.","DailyReturn":"14.7%","FiveDayReturnAfter":"13.83%","FiveDayReturnBefore":"2.4%"},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Neutral. Target Price is $130; previously $110.","DailyReturn":"14.7%","FiveDayReturnAfter":"13.83%","FiveDayReturnBefore":"2.4%"},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $130; previously $105.","DailyReturn":"14.7%","FiveDayReturnAfter":"13.83%","FiveDayReturnBefore":"2.4%"},{"Ticker":"AVGO","EffectiveDate":"2015-02-25","Type":"EarningsBeatRevenueMiss","Title":"After market close, AVGO reports 2015 Q1's earning $2.09 per share and revenue $1635MM. This beats analyst's estimated EPS $1.93, misses estimated revenue $1640MM.","DailyReturn":"-0.44%","FiveDayReturnAfter":"12.47%","FiveDayReturnBefore":"2.06%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-17","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":"2.07%","FiveDayReturnAfter":"3.84%","FiveDayReturnBefore":"-5.31%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $115; previously $108.","DailyReturn":"1.3%","FiveDayReturnAfter":"0.09%","FiveDayReturnBefore":"4.23%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $110; previously $105.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $115; previously $100.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Bank of America maintains AVGO to Buy. Target Price is $118; previously $100.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Hold. Target Price is $104; previously $84.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $100; previously $84.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $120; previously $105.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $125; previously $105.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $110; previously $96.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $120; previously $100.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $108; previously $100.","DailyReturn":"8.34%","FiveDayReturnAfter":"4.23%","FiveDayReturnBefore":"4.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-03","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q4's earning $1.99 per share and revenue $1610MM. This beats analyst's estimated EPS $1.68, beats estimated revenue $1550MM.","DailyReturn":"3.17%","FiveDayReturnAfter":"10.72%","FiveDayReturnBefore":"1.15%"},{"Ticker":"AVGO","EffectiveDate":"2014-12-02","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $105; previously $87.","DailyReturn":"1.37%","FiveDayReturnAfter":"10.19%","FiveDayReturnBefore":"0.81%"},{"Ticker":"AVGO","EffectiveDate":"2014-11-25","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $96; previously $90.","DailyReturn":"0.01%","FiveDayReturnAfter":"1.15%","FiveDayReturnBefore":"2.91%"},{"Ticker":"AVGO","EffectiveDate":"2014-10-16","Type":"RatingUpgrade","Title":"Brean Capital upgrades AVGO to Buy from Hold. Target Price is $87.","DailyReturn":"4.2%","FiveDayReturnAfter":"10.84%","FiveDayReturnBefore":"-13.81%"},{"Ticker":"AVGO","EffectiveDate":"2014-10-06","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $97; previously $95.","DailyReturn":"-0.7%","FiveDayReturnAfter":"-15.67%","FiveDayReturnBefore":"-4.71%"},{"Ticker":"AVGO","EffectiveDate":"2014-09-30","Type":"RatingNeutral","Title":"Nomura maintains AVGO. Target Price is $95; previously $85.","DailyReturn":"-0.12%","FiveDayReturnAfter":"-4.97%","FiveDayReturnBefore":"-0.08%"},{"Ticker":"AVGO","EffectiveDate":"2014-09-17","Type":"Dividend","Title":"The Firm pays dividend $0.32","DailyReturn":"0.15%","FiveDayReturnAfter":"-0.04%","FiveDayReturnBefore":"-0.55%"},{"Ticker":"AVGO","EffectiveDate":"2014-09-09","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $100; previously $90.","DailyReturn":"0.24%","FiveDayReturnAfter":"-1.69%","FiveDayReturnBefore":"7.16%"},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $88; previously $84.","DailyReturn":"7.5%","FiveDayReturnAfter":"14.05%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $90; previously $80.","DailyReturn":"7.5%","FiveDayReturnAfter":"14.05%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $100; previously $85.","DailyReturn":"7.5%","FiveDayReturnAfter":"14.05%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $105; previously $75.","DailyReturn":"7.5%","FiveDayReturnAfter":"14.05%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2014-08-28","Type":"EarningsBeatRevenueMiss","Title":"After market close, AVGO reports 2014 Q3's earning $1.26 per share and revenue $1270MM. This beats analyst's estimated EPS $1.05, misses estimated revenue $1350MM.","DailyReturn":"0.26%","FiveDayReturnAfter":"12.25%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"AVGO","EffectiveDate":"2014-07-14","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $90; previously $46.","DailyReturn":"1.14%","FiveDayReturnAfter":"2.42%","FiveDayReturnBefore":"-2.66%"},{"Ticker":"AVGO","EffectiveDate":"2014-06-17","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":"1.26%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"-1.27%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-30","Type":"RatingNeutral","Title":"Raymond James maintains AVGO to Outperform. Target Price is $83; previously $65.","DailyReturn":"-0.16%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"3.41%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-29","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q2's earning $0.85 per share and revenue $701MM. This beats analyst's estimated EPS $0.76, beats estimated revenue $679.59MM.","DailyReturn":"0.98%","FiveDayReturnAfter":"2.13%","FiveDayReturnBefore":"3.74%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on AVGO to Buy. Target Price is $80.","DailyReturn":"-0.36%","FiveDayReturnAfter":"-1.82%","FiveDayReturnBefore":"2.08%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-13","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $75; previously $70.","DailyReturn":"-0.53%","FiveDayReturnAfter":"-1.17%","FiveDayReturnBefore":"7.32%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"Barclays initiates coverage on AVGO to Overweight. Target Price is $85.","DailyReturn":"-0.79%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"6.78%"},{"Ticker":"AVGO","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Outperform from Outperform. Target Price is $85; previously $85.","DailyReturn":"-0.79%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"6.78%"},{"Ticker":"AVGO","EffectiveDate":"2014-04-07","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $70; previously $66.","DailyReturn":"-2.33%","FiveDayReturnAfter":"-5.43%","FiveDayReturnBefore":"-3.66%"},{"Ticker":"AVGO","EffectiveDate":"2014-03-28","Type":"RatingNeutral","Title":"Pacific Crest initiates coverage on AVGO to Outperform. Target Price is $75.","DailyReturn":"2.11%","FiveDayReturnAfter":"1.81%","FiveDayReturnBefore":"-3.95%"},{"Ticker":"AVGO","EffectiveDate":"2014-03-18","Type":"Dividend","Title":"The Firm pays dividend $0.27","DailyReturn":"1.07%","FiveDayReturnAfter":"0.03%","FiveDayReturnBefore":"0.96%"},{"Ticker":"AVGO","EffectiveDate":"2014-02-25","Type":"RatingNeutral","Title":"Raymond James initiates coverage on AVGO to Outperform. Target Price is $65.","DailyReturn":"-0.95%","FiveDayReturnAfter":"3.57%","FiveDayReturnBefore":"2.53%"},{"Ticker":"AVGO","EffectiveDate":"2014-02-25","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q1's earning $0.84 per share and revenue $709MM. This beats analyst's estimated EPS $0.78, beats estimated revenue $705.29MM.","DailyReturn":"-0.95%","FiveDayReturnAfter":"3.57%","FiveDayReturnBefore":"2.53%"},{"Ticker":"AVGO","EffectiveDate":"2014-02-14","Type":"RatingNeutral","Title":"DA Davidson downgrades AVGO to Neutral from Buy. Target Price is $64; previously $60.","DailyReturn":"-1.69%","FiveDayReturnAfter":"-0.9%","FiveDayReturnBefore":"6.79%"},{"Ticker":"AVGO","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"JMP Securities downgrades AVGO to Market Perform from Market Outperform.","DailyReturn":"0.23%","FiveDayReturnAfter":"0.1%","FiveDayReturnBefore":"8.79%"},{"Ticker":"AVGO","EffectiveDate":"2014-02-12","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $70; previously $60.","DailyReturn":"1.49%","FiveDayReturnAfter":"-0.63%","FiveDayReturnBefore":"7.24%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-18","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.3%","FiveDayReturnAfter":"-1.3%","FiveDayReturnBefore":"13.92%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-17","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $60; previously $46.","DailyReturn":"6.9%","FiveDayReturnAfter":"4.3%","FiveDayReturnBefore":"5.6%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-16","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Buy. Target Price is $60; previously $55.","DailyReturn":"9.74%","FiveDayReturnAfter":"12.81%","FiveDayReturnBefore":"-2.82%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-12","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on AVGO to Outperform. Target Price is $60.","DailyReturn":"-0.78%","FiveDayReturnAfter":"14.67%","FiveDayReturnBefore":"3.55%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-04","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Neutral. Target Price is $46; previously $40.","DailyReturn":"-0.62%","FiveDayReturnAfter":"3.98%","FiveDayReturnBefore":"2.41%"},{"Ticker":"AVGO","EffectiveDate":"2013-12-02","Type":"RatingUpgrade","Title":"DA Davidson upgrades AVGO to Buy from Neutral. Target Price is $55; previously $41.","DailyReturn":"0.6%","FiveDayReturnAfter":"4.86%","FiveDayReturnBefore":"3.82%"},{"Ticker":"AVGO","EffectiveDate":"2013-11-12","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on AVGO to Buy. Target Price is $53.","DailyReturn":"2.08%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"-1.86%"},{"Ticker":"AVGO","EffectiveDate":"2013-10-18","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades AVGO to Conviction Buy from Buy. Target Price is $54; previously $48.","DailyReturn":"2.12%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"3.58%"},{"Ticker":"AVGO","EffectiveDate":"2013-10-03","Type":"RatingNeutral","Title":"Charter Equity downgrades AVGO to Buy from Strong Buy.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-2.82%","FiveDayReturnBefore":"2.8%"},{"Ticker":"AVGO","EffectiveDate":"2013-09-17","Type":"Dividend","Title":"The Firm pays dividend $0.23","DailyReturn":"2.74%","FiveDayReturnAfter":"6.97%","FiveDayReturnBefore":"1.3%"},{"Ticker":"AVGO","EffectiveDate":"2013-09-17","Type":"RatingUpgrade","Title":"JMP Securities upgrades AVGO to Market Outperform from Market Perform. Target Price is $55.","DailyReturn":"2.74%","FiveDayReturnAfter":"6.97%","FiveDayReturnBefore":"1.3%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $45; previously $43.","DailyReturn":"4.73%","FiveDayReturnAfter":"6.43%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $42; previously $40.","DailyReturn":"4.73%","FiveDayReturnAfter":"6.43%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $41; previously $39.","DailyReturn":"4.73%","FiveDayReturnAfter":"6.43%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-27","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on AVGO to Market Perform.","DailyReturn":"-2.48%","FiveDayReturnAfter":"2.29%","FiveDayReturnBefore":"3.33%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-27","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2013 Q3's earning $0.74 per share and revenue $644MM. This beats analyst's estimated EPS $0.61, beats estimated revenue $622.78MM.","DailyReturn":"-2.48%","FiveDayReturnAfter":"2.29%","FiveDayReturnBefore":"3.33%"},{"Ticker":"AVGO","EffectiveDate":"2013-08-15","Type":"RatingNeutral","Title":"Brean Capital downgrades AVGO to Hold from Buy; previously $43.","DailyReturn":"-3.22%","FiveDayReturnAfter":"-1.7%","FiveDayReturnBefore":"-0.18%"},{"Ticker":"AVGO","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Citigroup downgrades AVGO to Neutral from Buy.","DailyReturn":"0.02%","FiveDayReturnAfter":"-0.57%","FiveDayReturnBefore":"-5.35%"},{"Ticker":"AVGO","EffectiveDate":"2013-07-11","Type":"RatingNeutral","Title":"Jefferies downgrades AVGO to Hold from Buy. Target Price is $42.","DailyReturn":"0.67%","FiveDayReturnAfter":"1.52%","FiveDayReturnBefore":"-0.39%"},{"Ticker":"AVGO","EffectiveDate":"2013-07-02","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on AVGO to Overweight. Target Price is $45.","DailyReturn":"2.31%","FiveDayReturnAfter":"-0.07%","FiveDayReturnBefore":"2.47%"},{"Ticker":"AVGO","EffectiveDate":"2013-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.21","DailyReturn":"3.74%","FiveDayReturnAfter":"6.23%","FiveDayReturnBefore":"-2.79%"},{"Ticker":"AVGO","EffectiveDate":"2013-05-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $45; previously $40.","DailyReturn":"9.84%","FiveDayReturnAfter":"7.19%","FiveDayReturnBefore":"-1.89%"},{"Ticker":"AVGO","EffectiveDate":"2013-05-29","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2013 Q2's earning $0.61 per share and revenue $562MM. This beats analyst's estimated EPS $0.53, beats estimated revenue $557.78MM.","DailyReturn":"-0.02%","FiveDayReturnAfter":"9.3%","FiveDayReturnBefore":"0%"},{"Ticker":"AVGO","EffectiveDate":"2013-03-21","Type":"Dividend","Title":"The Firm pays dividend $0.19","DailyReturn":"-0.5%","FiveDayReturnAfter":"-0.28%","FiveDayReturnBefore":"-0.16%"},{"Ticker":"AVGO","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $37; previously $38.","DailyReturn":"1.69%","FiveDayReturnAfter":"3.55%","FiveDayReturnBefore":"-7.02%"},{"Ticker":"AVGO","EffectiveDate":"2013-02-26","Type":"EarningBeat","Title":"After market close, AVGO reports 2013 Q1's earning $0.65 per share and revenue $576MM. This beats analyst's estimated EPS $0.55, meets estimated revenue $576MM.","DailyReturn":"0.54%","FiveDayReturnAfter":"1.77%","FiveDayReturnBefore":"-6.43%"},{"Ticker":"AVGO","EffectiveDate":"2013-01-09","Type":"RatingNeutral","Title":"Topeka initiates coverage on AVGO to Buy. Target Price is $40.","DailyReturn":"2.21%","FiveDayReturnAfter":"5.36%","FiveDayReturnBefore":"1.41%"},{"Ticker":"AVGO","EffectiveDate":"2012-12-13","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades AVGO to Buy from Neutral. Target Price is $44; previously $40.","DailyReturn":"-2.03%","FiveDayReturnAfter":"-7.26%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2012-12-13","Type":"Dividend","Title":"The Firm pays dividend $0.17","DailyReturn":"-2.03%","FiveDayReturnAfter":"-7.26%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AVGO","EffectiveDate":"2012-11-30","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $38.","DailyReturn":"0%","FiveDayReturnAfter":"0.05%","FiveDayReturnBefore":"6.71%"},{"Ticker":"AVGO","EffectiveDate":"2012-11-29","Type":"EarningsMissRevenueBeat","Title":"AVGO reports 2012 Q4's earning $0.64 per share and revenue $618MM. This misses analyst's estimated EPS $0.67, beats estimated revenue $614.98MM.","DailyReturn":"1.56%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"5.19%"},{"Ticker":"AVGO","EffectiveDate":"2012-11-27","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $38.","DailyReturn":"0.23%","FiveDayReturnAfter":"2.23%","FiveDayReturnBefore":"6.36%"},{"Ticker":"AVGO","EffectiveDate":"2012-11-05","Type":"RatingNeutral","Title":"DA Davidson downgrades AVGO to Neutral from Buy.","DailyReturn":"1.03%","FiveDayReturnAfter":"-1.45%","FiveDayReturnBefore":"3.71%"},{"Ticker":"AVGO","EffectiveDate":"2012-10-03","Type":"RatingNeutral","Title":"Capstone initiates coverage on AVGO to Buy. Target Price is $40.","DailyReturn":"0.43%","FiveDayReturnAfter":"-2.44%","FiveDayReturnBefore":"4.18%"},{"Ticker":"AVGO","EffectiveDate":"2012-09-18","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.11%","FiveDayReturnAfter":"-1.49%","FiveDayReturnBefore":"0.79%"},{"Ticker":"AVGO","EffectiveDate":"2012-09-04","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $40; previously $43.","DailyReturn":"-1.85%","FiveDayReturnAfter":"-4.38%","FiveDayReturnBefore":"1.43%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-17","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $43; previously $42.","DailyReturn":"-0.18%","FiveDayReturnAfter":"-2.44%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-17","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $43; previously $42.","DailyReturn":"-0.18%","FiveDayReturnAfter":"-2.44%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-16","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2012 Q3's earning $0.72 per share and revenue $606MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $600.74MM.","DailyReturn":"0.9%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-2.43%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-14","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $45; previously $39.","DailyReturn":"-0.33%","FiveDayReturnAfter":"-0.85%","FiveDayReturnBefore":"-2.18%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-13","Type":"RatingNeutral","Title":"UBS initiates coverage on AVGO to Buy. Target Price is $43.","DailyReturn":"-2.36%","FiveDayReturnAfter":"-0.83%","FiveDayReturnBefore":"0.1%"},{"Ticker":"AVGO","EffectiveDate":"2012-08-02","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on AVGO to Neutral. Target Price is $40.","DailyReturn":"-0.4%","FiveDayReturnAfter":"2.13%","FiveDayReturnBefore":"6.99%"},{"Ticker":"AVGO","EffectiveDate":"2012-07-24","Type":"RatingNeutral","Title":"Canaccord Genuity initiates coverage on AVGO to Buy. Target Price is $42.","DailyReturn":"-0.89%","FiveDayReturnAfter":"4.2%","FiveDayReturnBefore":"5.2%"},{"Ticker":"AVGO","EffectiveDate":"2012-06-14","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-1.71%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"3.19%"},{"Ticker":"AVGO","EffectiveDate":"2012-05-23","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Neutral. Target Price is $32; previously $33.","DailyReturn":"7.19%","FiveDayReturnAfter":"5.56%","FiveDayReturnBefore":"0.7%"},{"Ticker":"AVGO","EffectiveDate":"2012-05-16","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $39; previously $44.","DailyReturn":"-0.9%","FiveDayReturnAfter":"0.7%","FiveDayReturnBefore":"-1.59%"},{"Ticker":"AVGO","EffectiveDate":"2012-03-15","Type":"Dividend","Title":"The Firm pays dividend $0.13","DailyReturn":"2.1%","FiveDayReturnAfter":"3.66%","FiveDayReturnBefore":"3.73%"},{"Ticker":"AVGO","EffectiveDate":"2012-02-23","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $44; previously $43.","DailyReturn":"3.59%","FiveDayReturnAfter":"4.65%","FiveDayReturnBefore":"3.94%"}];